Journal of Medical Screening

Papers
(The median citation count of Journal of Medical Screening is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
The impact of episodic screening interruption: COVID-19 and population-based cancer screening in Canada126
Benefits and harms of breast cancer mammography screening for women at average risk of breast cancer: A systematic review for the European Commission Initiative on Breast Cancer50
Impact of COVID-19-related care disruptions on cervical cancer screening in the United States34
COVID-19 disruption to cervical cancer screening in England24
Assessing the impact of the COVID-19 pandemic on breast cancer screening and diagnosis rates: A rapid review and meta-analysis24
Google search volume trends for cancer screening terms during the COVID-19 pandemic22
Incidence of inborn errors of metabolism detected by tandem mass spectrometry in China: A census of over seven million newborns between 2016 and 201720
Cervical screening attendance and cervical cancer risk among women who have sex with women19
Folic acid and neural tube defects: Discovery, debate and the need for policy change19
The randomized trial of mammography screening that was not—A cautionary tale18
Assessment of breast positioning criteria in mammographic screening: Agreement between artificial intelligence software and radiographers17
Self-sampling for cervical screening offered at the point of invitation: A cross-sectional study of preferences in England14
Retrospective analysis of the effect on interval cancer rate of adding an artificial intelligence algorithm to the reading process for two-dimensional full-field digital mammography13
Newborn screening for inherited metabolic diseases using tandem mass spectrometry in China: Outcome and cost–utility analysis13
Gender-specific cut-off levels in colorectal cancer screening with fecal immunochemical test: A population-based study of colonoscopy findings and costs12
A novel mobile phone application for infant stool color recognition: An easy and effective tool to identify acholic stools in newborns12
Prioritisation of colonoscopy services in colorectal cancer screening programmes to minimise impact of COVID-19 pandemic on predicted cancer burden: A comparative modelling study10
Modeling costs and benefits of the organized colorectal cancer screening programme and its potential future improvements in Hungary10
Human papillomavirus self-sampling for long-term non-attenders in cervical cancer screening: A randomised feasibility study in Estonia10
Women screened for breast cancer are dying from lung cancer: An opportunity to improve lung cancer screening in a mammography population9
The UK National Screening Committee’s position on child–parent screening for familial hypercholesterolaemia9
Maximising the acceptability of extended time intervals between screens in the NHS Cervical Screening Programme: An online experimental study9
Screening asymptomatic men for prostate cancer: A comparison of international guidelines on prostate-specific antigen testing9
Systematic review and meta-analysis of colon capsule endoscopy accuracy for colorectal cancer screening. An alternative during the Covid-19 pandemic?9
All-cause mortality as the primary endpoint for the GRAIL/National Health Service England multi-cancer screening trial9
Faecal haemoglobin concentrations in women and men diagnosed with colorectal cancer in a national screening programme9
Colorectal cancer mortality after randomized implementation of FIT-based screening - a nationwide cohort study9
Screening participants’ attitudes to the introduction of artificial intelligence in breast screening8
Test accuracy of artificial intelligence-based grading of fundus images in diabetic retinopathy screening: A systematic review8
Cost-effectiveness analysis of lung cancer screening with low-dose computed tomography in an Iranian high-risk population8
Retrospective comparison between single reading plus an artificial intelligence algorithm and two-view digital tomosynthesis with double reading in breast screening8
Impact of the COVID-19 pandemic on colorectal cancer screening in New York City7
The prevalence of comorbidity in the lung cancer screening population: A systematic review and meta-analysis7
Acceptability of alternative technologies compared with faecal immunochemical test and/or colonoscopy in colorectal cancer screening: A systematic review7
Benefits of digital breast tomosynthesis: A lesion-level analysis6
Faecal immunochemical testing in bowel cancer screening: Estimating outcomes for different diagnostic policies6
Prenatal serum screening for Down syndrome and neural tube defects in the United States: Changes in utilization patterns from 2012 to 20206
Feasibility of population-based screening of sickle cell disease through the primary health care system in tribal areas of India5
Major failings of trial procedures and quality of screening fatally compromise the results of the Canadian National Breast Screening Studies5
Breast cancer mortality after eight years of an improved screening program using digital breast tomosynthesis5
Did the use of open invitations in place of timed appointment invitations reduce the uptake of breast screening in the London region during the COVID-19 recovery?5
Awareness and knowledge about HPV and primary HPV screening among women in Great Britain: An online population-based survey5
Evaluation of benefits and harms of adaptive screening schedules for lung cancer: A microsimulation study4
The impact of cumulative colorectal cancer screening delays: A simulation study4
HPV self-sampling and follow-up over two rounds of cervical screening in Australia – the iPap trial4
Beneficial effect of repeated participation in breast cancer screening upon survival4
Quality measures of a multicentre universal newborn hearing screening program in Malaysia4
Door-to-door hepatitis C screening in Georgia: An innovative model to increase testing and linkage to care4
The impact of the COVID-19 pandemic on breast cancer screening and diagnosis in a Brazilian metropolitan area4
Trends in colorectal cancer screening in the United States, 2012 to 20204
Interval cancer audit and disclosure in cervical screening programmes: An international survey3
Interval cancers in a population-based screening program for colorectal cancer with gender-specific cut-off levels for fecal immunochemical test3
Implementation of a centralized HPV-based cervical cancer screening programme in Tuscany: First round results and comparison with the foregoing Pap-based screening programme3
Overcoming barriers to lung cancer screening using a systemwide approach with additional focus on the non-screened3
Predicting perinatal outcomes with an obstructive sleep apnea screening tool3
Impact of changing from a guaiac faecal occult blood test to a faecal immunochemical test in a national screening programme: Results from a pilot study within the national bowel cancer screening progr2
Clinical performance and utility: A microsimulation model to inform the design of screening trials for a multi-cancer early detection test2
Differential impact of test performance characteristics on burden-to-benefit tradeoffs for blood-based colorectal cancer screening: A microsimulation analysis2
Estimating stage-specific sensitivity for cancer screening tests2
Colonoscopy may be weak link in organised colorectal cancer screening programme with faecal immunochemical test2
Comparison of cytology and human papillomavirus-based primary testing in cervical screening programs in the Nordic countries2
Strong association between reduction of late-stage cancers and reduction of cancer-specific mortality in meta-regression of randomized screening trials across multiple cancer types2
Comparison with first round findings of faecal haemoglobin concentrations and clinical outcomes in the second round of a biennial faecal immunochemical test based colorectal cancer screening programme2
Comparing screening based on the NHS Health Check and Polypill Prevention Programmes in the primary prevention of heart attacks and strokes2
Selection of patients for large mailed fecal immunochemical test colorectal cancer screening outreach programs: A systematic review2
Availability of data for cost-effectiveness comparison of child vision and hearing screening programmes2
Evaluation of the Call for a Kit intervention to increase bowel cancer screening uptake in Lancashire, England2
NHS announces a pilot of a blood test for early detection of many cancers2
Factors associated with test failure in pregnant women undergoing cell-free DNA-based testing for fetal trisomy2
Why are most colorectal cancers diagnosed outside of screening? A retrospective analysis of data from the English bowel screening programme2
Timely adherence to follow-up after high-risk lung cancer screenings2
Hybrid capture 2 and cobas® 4800: Comparison of performance of two clinically validated tests for human papillomavirus primary screening of cervical cancer2
Classifying interval cancers as false negatives or newly occurring in fecal immunochemical testing2
“It's cancer screening after all”. Barriers to cervical and colorectal cancer screening and attitudes to promotion of self-sampling kits upon attendance for breast cancer screening2
Factors associated with women's supplemental screening intentions following dense breast notification in an online randomised experimental study1
Overcoming barriers: Modelling the effect of potential future changes of organized breast cancer screening in Italy1
Risk or chance1
Age at breast cancer screening in women with intellectual disability1
The prognostic potential of mammographic growth rate of invasive breast cancer in the Nijmegen breast cancer screening cohort1
Cell-free DNA-based prenatal screening via rolling circle amplification: Identifying and resolving analytic issues1
Colorectal cancer screening with faecal immunochemical test: Patterns of participation1
Response to Editorial: ‘Risk or chance’1
Impact of switching from digital mammography to tomosynthesis plus digital mammography on breast cancer screening in Alberta, Canada1
Interval cancer after two rounds of a Swedish population-based screening program using gender-specific cut-off levels in fecal immunochemical test1
Newborn screening for abnormal haemoglobins in Jamaica: Practical issues in an island programme1
How follow-up rates in cervical cancer screening depend on organizational factors: A comparison of two population-based organized screening programmes1
Association between time to colonoscopy after positive fecal testing and colorectal cancer outcomes in Alberta, Canada1
Efficacy and effectiveness1
All-cause mortality in multi-cancer screening trials1
Wide variability in colorectal cancer screening uptake by general practitioner: Cross-sectional study1
Recovery of the breast screening programme following pandemic-related delays: Should we focus on round length or uptake?1
Including the method of detection for breast cancer in the Surveillance, Epidemiology, and End Results database is long overdue1
Age-specific differences in tumour characteristics between screen-detected and non-screen-detected breast cancers in women aged 40–74 at diagnosis in Sweden from 2008 to 20171
Multi-marker risk-based screening for prostate cancer1
Outcome of premarital genetic counseling for couples at risk of hemoglobinopathies in Kingdom of Bahrain1
Participation and cancer detection after reminders versus ordinary invitations in BreastScreen Norway1
Temporal and area-level variation in prevalence of high-grade histologically confirmed cervical abnormalities among Indigenous and non-Indigenous women, Queensland, Australia, 2008–20171
Optimising recruitment to a lung cancer screening trial: A comparison of general practitioner and community-based recruitment1
Guidance on terminology1
Long-term cause of death patterns and mode of breast cancer detection in The Netherlands, 2004−20191
Examining the impact of COVID-19 disruptions on population-based breast cancer screening in Ireland1
Reducing inequalities by supporting individuals to make informed decisions about accepting their breast screening invitations1
Interval cancer audit and disclosure in breast screening programmes: An international survey1
Ethics of screening promotion: A slippery slope to forced marketing?1
Public cervical cancer screening recommendations from US cancer centers: Assessing adherence to national guidelines1
Populations at high risk of cervical cancer in Guangxi Province: Findings from two screening projects in a minority area of South China1
One or two faecal immunochemical tests in an organised population-based colorectal cancer screening programme in Murcia (Spain)1
The Risk-Screening Converter1
Infants with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome/cystic fibrosis screen positive, inconclusive diagnosis and acute recurrent pancreatitis: what definition?1
0.030114889144897